 Richard Duke
Concepts (285)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Membrane Glycoproteins | 18 | 2004 | 465 | 0.950 |
Why?
| | Apoptosis | 22 | 2012 | 2481 | 0.930 |
Why?
| | Fas Ligand Protein | 17 | 2012 | 59 | 0.770 |
Why?
| | T-Lymphocytes, Cytotoxic | 9 | 2006 | 166 | 0.700 |
Why?
| | Cytotoxicity, Immunologic | 11 | 2004 | 214 | 0.480 |
Why?
| | Genetic Therapy | 4 | 2012 | 292 | 0.420 |
Why?
| | Killer Cells, Natural | 3 | 2004 | 422 | 0.360 |
Why?
| | fas Receptor | 8 | 2004 | 96 | 0.360 |
Why?
| | Bone Neoplasms | 1 | 2012 | 227 | 0.330 |
Why?
| | T-Lymphocytes, Helper-Inducer | 2 | 2006 | 137 | 0.310 |
Why?
| | Chromatin | 3 | 2004 | 470 | 0.310 |
Why?
| | Immunotherapy | 5 | 2010 | 579 | 0.310 |
Why?
| | Viral Hepatitis Vaccines | 1 | 2006 | 1 | 0.270 |
Why?
| | Viral Core Proteins | 1 | 2006 | 21 | 0.270 |
Why?
| | T-Lymphocytes | 11 | 2004 | 1905 | 0.270 |
Why?
| | Saccharomyces cerevisiae | 4 | 2010 | 517 | 0.260 |
Why?
| | Viral Nonstructural Proteins | 1 | 2006 | 58 | 0.260 |
Why?
| | Hepacivirus | 1 | 2006 | 235 | 0.240 |
Why?
| | Transplantation Immunology | 2 | 1999 | 33 | 0.230 |
Why?
| | Recombinant Fusion Proteins | 2 | 2006 | 640 | 0.230 |
Why?
| | Biological Assay | 1 | 2004 | 117 | 0.210 |
Why?
| | Adenoviridae | 3 | 2004 | 193 | 0.200 |
Why?
| | Graft Rejection | 3 | 2002 | 566 | 0.190 |
Why?
| | Lymphoma, T-Cell, Cutaneous | 1 | 2001 | 42 | 0.180 |
Why?
| | Tumor Cells, Cultured | 13 | 2003 | 928 | 0.180 |
Why?
| | DNA Damage | 3 | 2001 | 377 | 0.170 |
Why?
| | Animals | 38 | 2012 | 34628 | 0.170 |
Why?
| | Prostatic Neoplasms | 4 | 1999 | 995 | 0.160 |
Why?
| | Testis | 2 | 1999 | 143 | 0.160 |
Why?
| | Mice | 27 | 2010 | 16543 | 0.150 |
Why?
| | Mice, Inbred BALB C | 8 | 2010 | 1230 | 0.140 |
Why?
| | Thymus Gland | 1 | 1999 | 303 | 0.140 |
Why?
| | Skin Neoplasms | 2 | 2002 | 828 | 0.140 |
Why?
| | Bacterial Toxins | 2 | 1996 | 107 | 0.140 |
Why?
| | Endonucleases | 4 | 1988 | 30 | 0.130 |
Why?
| | Viral Proteins | 1 | 1999 | 329 | 0.130 |
Why?
| | DNA | 7 | 1994 | 1406 | 0.120 |
Why?
| | Melitten | 1 | 1994 | 3 | 0.110 |
Why?
| | Valinomycin | 1 | 1994 | 4 | 0.110 |
Why?
| | Calcimycin | 1 | 1994 | 48 | 0.110 |
Why?
| | Hemolysin Proteins | 1 | 1994 | 34 | 0.110 |
Why?
| | Dogs | 2 | 2012 | 372 | 0.100 |
Why?
| | Lymphocyte Activation | 6 | 2004 | 1091 | 0.100 |
Why?
| | Interleukin-2 | 5 | 1998 | 427 | 0.100 |
Why?
| | Transfection | 3 | 1999 | 904 | 0.100 |
Why?
| | Necrosis | 2 | 2012 | 234 | 0.100 |
Why?
| | Vaccines, Synthetic | 3 | 2010 | 129 | 0.100 |
Why?
| | Osteosarcoma | 1 | 2012 | 74 | 0.090 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2010 | 62 | 0.090 |
Why?
| | CD4-Positive T-Lymphocytes | 4 | 2002 | 1040 | 0.080 |
Why?
| | Calcium | 3 | 1994 | 1173 | 0.080 |
Why?
| | Melanoma | 3 | 2003 | 735 | 0.080 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 110 | 0.080 |
Why?
| | Cancer Vaccines | 1 | 2010 | 164 | 0.080 |
Why?
| | AIDS Vaccines | 2 | 2001 | 47 | 0.080 |
Why?
| | Cytoplasmic Granules | 1 | 1988 | 82 | 0.080 |
Why?
| | Major Histocompatibility Complex | 1 | 1989 | 228 | 0.080 |
Why?
| | Cell Line | 7 | 1998 | 2759 | 0.070 |
Why?
| | Neoplasms, Experimental | 2 | 2004 | 168 | 0.070 |
Why?
| | Ionomycin | 2 | 2004 | 24 | 0.070 |
Why?
| | Mice, Inbred C57BL | 6 | 2010 | 5270 | 0.060 |
Why?
| | Lymphocyte Depletion | 1 | 1986 | 129 | 0.060 |
Why?
| | Mice, Inbred Strains | 4 | 2004 | 407 | 0.060 |
Why?
| | Autoimmunity | 2 | 2004 | 861 | 0.060 |
Why?
| | Yeasts | 1 | 2005 | 54 | 0.060 |
Why?
| | HeLa Cells | 1 | 2006 | 602 | 0.060 |
Why?
| | Lymphocytes | 4 | 1998 | 369 | 0.060 |
Why?
| | Ionophores | 1 | 2004 | 21 | 0.060 |
Why?
| | Egtazic Acid | 1 | 2004 | 42 | 0.060 |
Why?
| | DNA Fragmentation | 1 | 2004 | 46 | 0.060 |
Why?
| | Hepatitis C | 1 | 2006 | 234 | 0.060 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2004 | 150 | 0.060 |
Why?
| | In Situ Nick-End Labeling | 1 | 2004 | 125 | 0.060 |
Why?
| | Molecular Sequence Data | 5 | 2010 | 2842 | 0.050 |
Why?
| | Chelating Agents | 1 | 2004 | 68 | 0.050 |
Why?
| | Cell Survival | 4 | 1991 | 1082 | 0.050 |
Why?
| | Membrane Proteins | 1 | 1989 | 1100 | 0.050 |
Why?
| | Ultraviolet Rays | 2 | 2004 | 385 | 0.050 |
Why?
| | Dog Diseases | 1 | 2003 | 52 | 0.050 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2004 | 264 | 0.050 |
Why?
| | Cell Division | 3 | 2002 | 800 | 0.050 |
Why?
| | Arthritis, Experimental | 1 | 2004 | 128 | 0.050 |
Why?
| | Glucocorticoids | 3 | 1999 | 570 | 0.050 |
Why?
| | Antigens, Neoplasm | 1 | 2005 | 308 | 0.050 |
Why?
| | Genes, ras | 1 | 2002 | 97 | 0.050 |
Why?
| | Microscopy | 1 | 2004 | 140 | 0.050 |
Why?
| | Cytokines | 3 | 2006 | 1995 | 0.050 |
Why?
| | Fluorescent Dyes | 1 | 2004 | 319 | 0.050 |
Why?
| | PUVA Therapy | 1 | 2001 | 6 | 0.050 |
Why?
| | Humans | 23 | 2006 | 128896 | 0.050 |
Why?
| | Perforin | 2 | 1992 | 19 | 0.050 |
Why?
| | Immunity, Cellular | 2 | 2001 | 266 | 0.050 |
Why?
| | Pore Forming Cytotoxic Proteins | 2 | 1992 | 16 | 0.050 |
Why?
| | Transplantation, Homologous | 1 | 2002 | 403 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2001 | 163 | 0.040 |
Why?
| | DNA Primers | 3 | 1996 | 522 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2004 | 1312 | 0.040 |
Why?
| | Flow Cytometry | 3 | 1999 | 1146 | 0.040 |
Why?
| | Lung Neoplasms | 3 | 2004 | 2353 | 0.040 |
Why?
| | B-Lymphocytes | 2 | 1996 | 813 | 0.040 |
Why?
| | Antigens | 2 | 1992 | 346 | 0.040 |
Why?
| | HIV-1 | 2 | 1996 | 840 | 0.040 |
Why?
| | Base Sequence | 4 | 1996 | 2157 | 0.040 |
Why?
| | Lymphoma | 3 | 1998 | 190 | 0.040 |
Why?
| | MAP Kinase Kinase Kinase 1 | 1 | 1999 | 19 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2002 | 420 | 0.040 |
Why?
| | Phosphoprotein Phosphatases | 1 | 1999 | 67 | 0.040 |
Why?
| | Immediate-Early Proteins | 1 | 1999 | 58 | 0.040 |
Why?
| | Poxviridae | 1 | 1999 | 2 | 0.040 |
Why?
| | Cell Transplantation | 1 | 1999 | 35 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2006 | 3100 | 0.040 |
Why?
| | Spheroids, Cellular | 1 | 1999 | 70 | 0.040 |
Why?
| | I-kappa B Proteins | 1 | 1999 | 77 | 0.040 |
Why?
| | Myocarditis | 1 | 2000 | 101 | 0.040 |
Why?
| | Serpins | 1 | 1999 | 31 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 1999 | 190 | 0.040 |
Why?
| | Mice, Nude | 2 | 1999 | 680 | 0.040 |
Why?
| | Transduction, Genetic | 1 | 1999 | 128 | 0.040 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 1999 | 155 | 0.040 |
Why?
| | Receptors, Virus | 1 | 1998 | 81 | 0.040 |
Why?
| | Stress, Physiological | 1 | 2001 | 412 | 0.040 |
Why?
| | Depsipeptides | 1 | 1998 | 13 | 0.040 |
Why?
| | Cell Adhesion | 1 | 1999 | 452 | 0.040 |
Why?
| | Cell Nucleus | 3 | 1994 | 569 | 0.040 |
Why?
| | Toxoplasma | 1 | 1998 | 39 | 0.040 |
Why?
| | Dendritic Cells | 1 | 2001 | 478 | 0.040 |
Why?
| | Immunoglobulin M | 2 | 1998 | 268 | 0.040 |
Why?
| | Male | 12 | 2004 | 63146 | 0.040 |
Why?
| | Cell Death | 2 | 2004 | 342 | 0.030 |
Why?
| | Neoplasms | 2 | 2005 | 2426 | 0.030 |
Why?
| | HIV Envelope Protein gp160 | 1 | 1996 | 5 | 0.030 |
Why?
| | Molecular Weight | 2 | 1989 | 332 | 0.030 |
Why?
| | Microscopy, Electron, Scanning | 1 | 1996 | 194 | 0.030 |
Why?
| | Superantigens | 1 | 1996 | 71 | 0.030 |
Why?
| | Enterotoxins | 1 | 1996 | 89 | 0.030 |
Why?
| | Cerebrovascular Disorders | 1 | 1996 | 91 | 0.030 |
Why?
| | Tissue Transplantation | 1 | 1995 | 11 | 0.030 |
Why?
| | Cell Cycle | 1 | 1998 | 581 | 0.030 |
Why?
| | Sertoli Cells | 1 | 1995 | 24 | 0.030 |
Why?
| | Serine Endopeptidases | 1 | 1996 | 113 | 0.030 |
Why?
| | HIV Envelope Protein gp120 | 1 | 1995 | 58 | 0.030 |
Why?
| | Endodeoxyribonucleases | 2 | 1986 | 65 | 0.030 |
Why?
| | Rats | 2 | 1999 | 5236 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 1999 | 576 | 0.030 |
Why?
| | Macrophage Colony-Stimulating Factor | 1 | 1995 | 17 | 0.030 |
Why?
| | RNA, Messenger | 3 | 2002 | 2700 | 0.030 |
Why?
| | Alopecia Areata | 1 | 1995 | 9 | 0.030 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 1996 | 226 | 0.030 |
Why?
| | NF-kappa B | 1 | 1999 | 685 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 4 | 2001 | 822 | 0.030 |
Why?
| | Hair | 1 | 1995 | 73 | 0.030 |
Why?
| | Receptors, Complement | 1 | 1995 | 120 | 0.030 |
Why?
| | Cells, Cultured | 4 | 2001 | 4048 | 0.030 |
Why?
| | Mutation | 2 | 2004 | 3671 | 0.030 |
Why?
| | Virus Diseases | 1 | 1996 | 207 | 0.030 |
Why?
| | Salmonella typhimurium | 1 | 1995 | 174 | 0.030 |
Why?
| | Models, Biological | 1 | 2001 | 1702 | 0.030 |
Why?
| | Mitochondria | 1 | 1999 | 837 | 0.030 |
Why?
| | Immunization | 1 | 1995 | 416 | 0.030 |
Why?
| | Heart Diseases | 1 | 1996 | 356 | 0.030 |
Why?
| | Recombinant Proteins | 3 | 2004 | 1304 | 0.030 |
Why?
| | Spleen | 1 | 1995 | 518 | 0.030 |
Why?
| | Peptides | 1 | 1998 | 902 | 0.020 |
Why?
| | Fetus | 1 | 1996 | 764 | 0.020 |
Why?
| | Mice, Transgenic | 3 | 2002 | 2073 | 0.020 |
Why?
| | Protein Biosynthesis | 2 | 1984 | 409 | 0.020 |
Why?
| | Mice, Inbred DBA | 2 | 2004 | 182 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 1998 | 895 | 0.020 |
Why?
| | Amino Acid Sequence | 2 | 2010 | 2047 | 0.020 |
Why?
| | Leukemia, Experimental | 1 | 2010 | 27 | 0.020 |
Why?
| | Zinc | 2 | 1984 | 291 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2001 | 2038 | 0.020 |
Why?
| | Genes, MHC Class I | 1 | 2010 | 33 | 0.020 |
Why?
| | Cardiomegaly | 2 | 2002 | 172 | 0.020 |
Why?
| | Skin | 1 | 1995 | 737 | 0.020 |
Why?
| | In Vitro Techniques | 2 | 1989 | 1061 | 0.020 |
Why?
| | Enzyme Activation | 2 | 1999 | 811 | 0.020 |
Why?
| | Terminology as Topic | 1 | 1991 | 204 | 0.020 |
Why?
| | Dexamethasone | 2 | 1999 | 330 | 0.020 |
Why?
| | Lectins | 1 | 1989 | 46 | 0.020 |
Why?
| | Mast-Cell Sarcoma | 1 | 1988 | 4 | 0.020 |
Why?
| | Mice, Inbred CBA | 1 | 1988 | 51 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2010 | 657 | 0.020 |
Why?
| | Kidney | 1 | 1995 | 1330 | 0.020 |
Why?
| | Species Specificity | 1 | 1989 | 566 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2010 | 832 | 0.020 |
Why?
| | Oligosaccharides | 1 | 1988 | 57 | 0.020 |
Why?
| | Cell Separation | 1 | 1988 | 311 | 0.020 |
Why?
| | Histocompatibility Antigens | 1 | 1988 | 107 | 0.020 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 1991 | 699 | 0.020 |
Why?
| | Magnesium | 2 | 1985 | 151 | 0.020 |
Why?
| | Lymphocyte Culture Test, Mixed | 1 | 1986 | 48 | 0.020 |
Why?
| | Promoter Regions, Genetic | 2 | 2002 | 1194 | 0.020 |
Why?
| | Models, Molecular | 1 | 2010 | 1477 | 0.020 |
Why?
| | Urethane | 1 | 2004 | 41 | 0.010 |
Why?
| | Electrophoresis, Agar Gel | 1 | 1984 | 26 | 0.010 |
Why?
| | DNA, Neoplasm | 1 | 2004 | 162 | 0.010 |
Why?
| | Binding, Competitive | 1 | 1984 | 208 | 0.010 |
Why?
| | Adoptive Transfer | 1 | 2004 | 217 | 0.010 |
Why?
| | Antibodies | 2 | 1996 | 392 | 0.010 |
Why?
| | Corticosterone | 1 | 1984 | 214 | 0.010 |
Why?
| | Polymerase Chain Reaction | 2 | 1996 | 1045 | 0.010 |
Why?
| | CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2002 | 21 | 0.010 |
Why?
| | Carcinoma, Squamous Cell | 1 | 1988 | 626 | 0.010 |
Why?
| | Adenoma | 1 | 2004 | 210 | 0.010 |
Why?
| | Myosin Heavy Chains | 1 | 2002 | 173 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 957 | 0.010 |
Why?
| | HIV Infections | 1 | 1995 | 2696 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 2003 | 543 | 0.010 |
Why?
| | Receptors, Cell Surface | 1 | 2002 | 379 | 0.010 |
Why?
| | Cell Size | 1 | 2000 | 86 | 0.010 |
Why?
| | Kinetics | 1 | 1983 | 1619 | 0.010 |
Why?
| | Down-Regulation | 1 | 2002 | 637 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 10 | 1 | 1999 | 3 | 0.010 |
Why?
| | MAP Kinase Kinase Kinase 5 | 1 | 1999 | 3 | 0.010 |
Why?
| | Metallothionein | 1 | 1999 | 24 | 0.010 |
Why?
| | Dual Specificity Phosphatase 1 | 1 | 1999 | 26 | 0.010 |
Why?
| | Protein Phosphatase 1 | 1 | 1999 | 30 | 0.010 |
Why?
| | Phagocytosis | 2 | 1992 | 361 | 0.010 |
Why?
| | Phytohemagglutinins | 1 | 1999 | 28 | 0.010 |
Why?
| | Gene Dosage | 1 | 2000 | 143 | 0.010 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 1999 | 49 | 0.010 |
Why?
| | Transcription, Genetic | 2 | 1996 | 1408 | 0.010 |
Why?
| | Mitogens | 1 | 1999 | 58 | 0.010 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 1999 | 70 | 0.010 |
Why?
| | Hybridomas | 1 | 1999 | 234 | 0.010 |
Why?
| | Coxsackie and Adenovirus Receptor-Like Membrane Protein | 1 | 1998 | 7 | 0.010 |
Why?
| | Membrane Potentials | 1 | 1999 | 260 | 0.010 |
Why?
| | Thymus Neoplasms | 1 | 1998 | 22 | 0.010 |
Why?
| | Thymoma | 1 | 1998 | 31 | 0.010 |
Why?
| | CD3 Complex | 1 | 1998 | 99 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2002 | 728 | 0.010 |
Why?
| | Caspases | 1 | 1999 | 248 | 0.010 |
Why?
| | Cycloheximide | 1 | 1998 | 55 | 0.010 |
Why?
| | Dactinomycin | 1 | 1998 | 29 | 0.010 |
Why?
| | Androgens | 1 | 1999 | 173 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 1999 | 311 | 0.010 |
Why?
| | Gamma Rays | 1 | 1998 | 52 | 0.010 |
Why?
| | Mice, Inbred C3H | 1 | 1998 | 279 | 0.010 |
Why?
| | Fluorescent Antibody Technique | 1 | 1998 | 392 | 0.010 |
Why?
| | Transforming Growth Factor beta | 1 | 2000 | 460 | 0.010 |
Why?
| | Myocardium | 1 | 2002 | 981 | 0.010 |
Why?
| | Genetic Vectors | 1 | 1998 | 311 | 0.010 |
Why?
| | Proprotein Convertase 5 | 1 | 1996 | 1 | 0.010 |
Why?
| | Ligands | 1 | 1998 | 614 | 0.010 |
Why?
| | Protein-Tyrosine Kinases | 1 | 1999 | 421 | 0.010 |
Why?
| | Models, Immunological | 1 | 1996 | 94 | 0.010 |
Why?
| | DNA, Complementary | 1 | 1996 | 270 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 1998 | 608 | 0.010 |
Why?
| | Multigene Family | 1 | 1996 | 197 | 0.010 |
Why?
| | HIV Antibodies | 1 | 1995 | 58 | 0.010 |
Why?
| | Exudates and Transudates | 1 | 1995 | 12 | 0.010 |
Why?
| | Receptor Aggregation | 1 | 1995 | 9 | 0.010 |
Why?
| | Proto-Oncogenes | 1 | 1995 | 29 | 0.010 |
Why?
| | Peritoneum | 1 | 1995 | 40 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1996 | 536 | 0.010 |
Why?
| | Signal Transduction | 2 | 1998 | 4857 | 0.010 |
Why?
| | Antibodies, Bacterial | 1 | 1995 | 137 | 0.010 |
Why?
| | Rabbits | 1 | 1996 | 757 | 0.010 |
Why?
| | Antibody Formation | 1 | 1996 | 284 | 0.010 |
Why?
| | Plasmids | 1 | 1995 | 357 | 0.010 |
Why?
| | Reference Values | 1 | 1996 | 791 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 1998 | 1285 | 0.010 |
Why?
| | Mammals | 1 | 1996 | 267 | 0.010 |
Why?
| | Epidermis | 1 | 1995 | 156 | 0.010 |
Why?
| | Adult | 1 | 1996 | 35361 | 0.010 |
Why?
| | Gene Expression | 1 | 1999 | 1476 | 0.010 |
Why?
| | Keratinocytes | 1 | 1995 | 240 | 0.010 |
Why?
| | Administration, Oral | 1 | 1995 | 783 | 0.010 |
Why?
| | Interferon-gamma | 1 | 1996 | 759 | 0.010 |
Why?
| | Age Factors | 1 | 2000 | 3133 | 0.010 |
Why?
| | Staphylococcus aureus | 1 | 1996 | 429 | 0.010 |
Why?
| | Immunity, Innate | 1 | 1998 | 802 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 1996 | 834 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 1999 | 1423 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1996 | 1968 | 0.010 |
Why?
| | Phenotype | 1 | 1999 | 3059 | 0.010 |
Why?
| | CD4 Antigens | 1 | 1991 | 137 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 1995 | 569 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 1998 | 1701 | 0.000 |
Why?
| | Clone Cells | 1 | 1988 | 257 | 0.000 |
Why?
| | Neoplasm Transplantation | 1 | 1988 | 254 | 0.000 |
Why?
| | Interphase | 1 | 1985 | 31 | 0.000 |
Why?
| | Female | 2 | 2004 | 68162 | 0.000 |
Why?
| | Antibodies, Monoclonal | 1 | 1988 | 1359 | 0.000 |
Why?
|
|
Duke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|